News

09.03.2023

Stem Cell Therapy Now Available for People with MS in the Netherlands

In Mid-December 2022, it was announced that stem cell therapy (aHSCT) for a specific group of people with MS will…

How to set up a Multiple Sclerosis Registry? MSDA Academy Webinar Series

21.12.2022

One of the key strategic objectives of the MSDA Academy is to promote trustworthy and transparent practices in the use…

EMSP joins new EU funded project called More-EUROPA

21.12.2022

While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real-world data (RWD)…

21.12.2022

Romanian Youth with MS National Conference 2022

During November 18-20, 2022, the Romanian Association of Patients with Neurodegenerative Diseases (APAN) organized the fifth edition of the Youth…

Tyrolean MS Society takes a new approach to exchanging information with „look and listen“

21.12.2022

The COVID-19 pandemic heralded a time in which the Tyrolean MS society had to and was allowed to deal with…

MS Data Alliance Stakeholder Engagement Meeting 2022

30.11.2022

On 16 November 2022 EMSP representatives (Herbert Temmes, Jana Hlaváčová, and Mohsharif Nasrulloeva) participated in the 2nd MS Data Alliance…

30.11.2022

Krapina-Zagorje Regional MS Society of the Croatian National MS Society Celebrates 20 Years Anniversary

Guest Blog Post by Nataša Hlaban, EMSP Board Member and Project Coordinator at the Regional MS Society in Krapina-Zagorje County,…

Presentation of the first Multiple Sclerosis Registry in Spain: EMDATA

30.11.2022

About EMDATA The EMDATA (In English: MSDATA) project in Spain aims to collect and store information of interest on issues…

Italian MS Society launches collaboration with the National Civil Protection Service

30.11.2022

The Italian MS Society (AISM) has recently signed a memorandum of understanding with the Department of Civil Protection in Italy, an…

1 7 8 9 10 11 67